U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. OCE Annual Reports
  6. 2022 OCE Annual Report
  7. Professional Education
  1. 2022 OCE Annual Report

Professional Education

Professional Education

Project Socrates

In 2022, Project Socrates completed its third year, having continued many of its educational programs while also establishing new initiatives. These programs and initiatives complemented the goal of Project Socrates of building an educational network bridging the OCE and the public, focusing on regulatory policy and science. 

Educational Initiatives for Oncology Professionals

Project Socrates’ partnerships with professional societies extended the OCE's breadth of educational outreach and engagement.

High School Summer Program

The OCE Summer Scholars Program welcomed 52 students to a six-week virtual learning experience in summer 2022 on cancer drug development and career opportunities in government, regulatory medicine, and cancer advocacy. The Summer Scholars Program began in 2017 as an in-person internship for up to 20 high-school students; it has since quadrupled in size and scope. Students from across the U.S. and abroad are now able to participate in this program. 

On September 14, 2022, current and former Summer Scholars participated in an OCE Conversation on Cancer titled Cancer Moonshot in Action: Launching the Next Generation of Cancer Leaders.

Educational Initiatives for FDA Reviewers

The OCE Icons in Oncology Distinguished Lecture Series welcomed Dr. Dennis Slamon, Dr. Anna Meadows, Dr. Gabriel Hortobagyi, and Dr. Paul Bunn, each of whom provided personal and historical perspectives of how research, treatment paradigms, and clinical trials in their respective fields in oncology have evolved over time. 

In 2022, the Icons in Oncology series was the first recurring OCE event approved for Continuing Education credits through the FDA CDER Office of Executive Programs, an accredited CE provider. This was coordinated by the OCE Continuing Education Program and Planning Committee, begun this past year by the Oncology Program Operations team.

In addition, Project Socrates held 34 classes as part of an internal OCE Curriculum to educate new reviewers on oncology regulatory policy and science. In 2022, the Office of Oncologic Diseases welcomed 30 new reviewers to FDA multi-disciplinary oncology review teams. 

FDA-AACR Oncology Educational Fellowship:

FDA-ASCO Hematology-Oncology Fellows Workshop: 
Hematology FDA
FDA-ASH Collaboration: A Workshop on Regulatory Science in Hematology:


Back to Top